Even with its high price tag, demand for Ozempic has exceeded production at many points in time, causing intermittent shortages and making the drug challenging for many Americans to obtain on demand
While Novo Nordisk currently has a head start, with 55% of drugs still in Phase 1 and competition heating up, the company must navigate challenges to maintain its meteoric growth
The FDA declared in February 2025 that the supply issues for both Ozempic and Wegovy have been resolved, reducing the need for compounded alternatives
They are currently being investigated as potential allies in preserving memory and preventing age -related brain damage
Zepbound and Weight Loss: The SURMOUNT Trial The safety and efficacy of Zepbound for chronic weight management were studied in two randomized, double-blind, placebo-controlled trials of obese or overweight adults who had at least one weight-related condition
And individual response varies significantly